Terms: = Ovarian cancer AND BCL2, Bcl-2, 596, ENSG00000171791
1250 results:
1. Effects of 5-fluorouracil, thymoquinone, and mammary stem cells' exosomes on
Abdelfattah-Hassan A; Ibrahim D; Saleh AA; Kishawy ATY; Mohamed RHA; Khater SI
Open Vet J; 2024 Jan; 14(1):525-533. PubMed ID: 38633189
[TBL] [Abstract] [Full Text] [Related]
2. High incidence of imperforate vagina in ADGRA3-deficient mice.
Kvam JM; Nybo ML; Torz L; Sustarsic RK; Jensen KHR; Nielsen JE; Frederiksen H; Gadgaard S; Spiess K; Poulsen SS; Thomsen JS; Cowin P; Blomberg Jensen M; Kurita T; Rosenkilde MM
BMC Biol; 2024 Apr; 22(1):77. PubMed ID: 38589878
[TBL] [Abstract] [Full Text] [Related]
3. Noscapine and Apoptosis in Breast and Other cancers.
Calaf GM; Crispin LA; Quisbert-Valenzuela EO
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542508
[TBL] [Abstract] [Full Text] [Related]
4. Harmaline induces apoptosis and inhibits migration in A2780 ovarian cancer cells in vitro.
Shariat Razavi SA; Taghdisi Khaboushan M; Jafari R; Shahini A; Ferns GA; Bahrami A
Physiol Rep; 2024 Mar; 12(6):e15984. PubMed ID: 38531560
[TBL] [Abstract] [Full Text] [Related]
5. Enhancing precision medicine: a nomogram for predicting platinum resistance in epithelial ovarian cancer.
Li R; Xiong Z; Ma Y; Li Y; Yang Y; Ma S; Ha C
World J Surg Oncol; 2024 Mar; 22(1):81. PubMed ID: 38509620
[TBL] [Abstract] [Full Text] [Related]
6. CRISPR du-HITI an attractive approach to targeting Long Noncoding RNA HCP5 as inhibitory factor for proliferation of ovarian cancer cell.
Moradi Z; Kazemi M; Jamshidi-Khalifelou R; Bahramnia V; Esfandmaz F; Rahnavard R; Moradgholi B; Piri-Gharaghie T
Funct Integr Genomics; 2024 Mar; 24(2):61. PubMed ID: 38507114
[TBL] [Abstract] [Full Text] [Related]
7. Static magnetic field reduces cisplatin resistance via increasing apoptosis pathways and genotoxicity in cancer cell lines.
Zafari J; Rastegar-Pouyani N; Javani Jouni F; Najjar N; Azarshin SZ; Jafarzadeh E; Abdolmaleki P; Hoseini Shirazi F
Sci Rep; 2024 Mar; 14(1):5792. PubMed ID: 38461218
[TBL] [Abstract] [Full Text] [Related]
8. VNP20009-Abvec-Igκ-MIIP suppresses ovarian cancer progression by modulating Ras/MEK/ERK signaling pathway.
Wang Q; Tang Y; Dai A; Li T; Pei Y; Zhang Z; Hu X; Chen T; Chen Q
Appl Microbiol Biotechnol; 2024 Feb; 108(1):218. PubMed ID: 38372808
[TBL] [Abstract] [Full Text] [Related]
9. HIF-2α-dependent TGFBI promotes ovarian cancer chemoresistance by activating PI3K/Akt pathway to inhibit apoptosis and facilitate DNA repair process.
Ma S; Wang J; Cui Z; Yang X; Cui X; Li X; Zhao L
Sci Rep; 2024 Feb; 14(1):3870. PubMed ID: 38365849
[TBL] [Abstract] [Full Text] [Related]
10. Paeonol impacts ovarian cancer cell proliferation, migration, invasion and apoptosis via modulating the transforming growth factor beta/smad3 signaling pathway.
Chen XM; Jia CL; Zhu ZY
J Physiol Pharmacol; 2023 Dec; 74(6):. PubMed ID: 38345445
[TBL] [Abstract] [Full Text] [Related]
11. Building an Efficient Peritoneal Surface Malignancies Program Despite the Lower-Middle-Income Barriers: Ukraine Experience.
Kopetskyi V; Antoniv M; Yarema R; Maksymovskyi V; Chetverikova-Ovchinnik V; Kryzhevskyi V; Volodko N; Gushchin V; Nikiforchin A
JCO Glob Oncol; 2024 Feb; 10():e2300432. PubMed ID: 38330272
[TBL] [Abstract] [Full Text] [Related]
12. Effects of rosmarinic acid and doxorubicine on an ovarian adenocarsinoma cell line (OVCAR3) via the EGFR pathway.
Sarı U; Zaman F
Acta Cir Bras; 2024; 39():e390524. PubMed ID: 38324801
[TBL] [Abstract] [Full Text] [Related]
13. WP1066, a small molecule inhibitor of STAT3, chemosensitizes paclitaxel-resistant ovarian cancer cells to paclitaxel by simultaneously inhibiting the activity of STAT3 and the interaction of STAT3 with Stathmin.
Yang J; Li N; Zhao X; Guo W; Wu Y; Nie C; Yuan Z
Biochem Pharmacol; 2024 Mar; 221():116040. PubMed ID: 38311257
[TBL] [Abstract] [Full Text] [Related]
14. Normal Risk ovarian Screening Study: 21-Year Update.
Han CY; Lu KH; Corrigan G; Perez A; Kohring SD; Celestino J; Bedi D; Bedia E; Bevers T; Boruta D; Carlson M; Holman L; Leeds L; Mathews C; McCann G; Moore RG; Schlumbrecht M; Slomovitz B; Tobias D; Williams-Brown Y; Bevers MW; Liu J; Gornet TG; Handy BC; Lu Z; Bedia JS; Skates SJ; Bast RC
J Clin Oncol; 2024 Apr; 42(10):1102-1109. PubMed ID: 38194613
[TBL] [Abstract] [Full Text] [Related]
15. Curcumin modulates cell type-specific miRNA networks to induce cytotoxicity in ovarian cancer cells.
Ravindran F; Mhatre A; Koroth J; Narayan S; Choudhary B
Life Sci; 2023 Dec; 334():122224. PubMed ID: 38084671
[TBL] [Abstract] [Full Text] [Related]
16. RUNX1 knockdown induced apoptosis and impaired EMT in high-grade serous ovarian cancer cells.
Chen Y; He Z; Yang S; Chen C; Xiong W; He Y; Liu S
J Transl Med; 2023 Dec; 21(1):886. PubMed ID: 38057816
[TBL] [Abstract] [Full Text] [Related]
17. Analysis of the Polymorphisms and Expression Levels of the bcl2, BAX and c-MYC Genes in Patients with ovarian cancer.
Olbromski PJ; Bogacz A; Bukowska M; Kamiński A; Moszyński R; Pawlik P; Szeliga A; Kotrych K; Czerny B
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003498
[TBL] [Abstract] [Full Text] [Related]
18. RNF144B-mediated p21 degradation regulated by HDAC3 contribute to enhancing ovarian cancer growth and metastasis.
Zhuang H; Zhang Z; Wang W; Qu H
Tissue Cell; 2024 Feb; 86():102277. PubMed ID: 37992458
[TBL] [Abstract] [Full Text] [Related]
19. Hederagenin suppresses ovarian cancer via targeting mitochondrial fission through dynamin-related protein 1.
Su F; Sui X; Xu J; Liu Q; Li J; Liu W; Xu Y; Zhang Z; Tao F
Eur J Pharmacol; 2024 Jan; 963():176188. PubMed ID: 37951490
[TBL] [Abstract] [Full Text] [Related]
20. Baicalein improves the chemoresistance of ovarian cancer through regulation of CirSLC7A6.
Li S; Yi Z; Li M; Zhu Z
J Ovarian Res; 2023 Nov; 16(1):212. PubMed ID: 37940982
[TBL] [Abstract] [Full Text] [Related]
[Next]
